Wondering if Exor could be excellent value right now? You're not alone, especially with mixed signals swirling in global markets. Exor's stock saw a modest 1.6% climb over the last week, but it's ...

Exor (ENXTAM:EXO) has quietly slipped over the past year, with shares down around 23% even as its underlying holdings like Ferrari and Stellantis keep executing. That gap is exactly what value focused ...

Add Yahoo as a preferred source to see more of our stories on Google. Exor logo is seen on investor day held by holding group in Turin MILAN (Reuters) -Italy's Agnelli family, whose investments ...

Philips resolved the Respironics litigation, settling for $1.1 billion. And Exor decided to boost its stake in the company. Supportive shareholders' remuneration is linked to Exor's portfolio results, ...

Exor’s FY24 performance was uninspiring, with Stellantis dragging down the very strong contribution from Ferrari. Recent actions—reducing Ferrari concentration, executing a large buyback, and ...

Has already invested almost 4 bln euros in healthcare Has cash firepower of 1.7 bln euros already allocated To receive around 1.1 bln euros in dividends during 2024 Exor NAV rose to 35.5 bln euros ...

MILAN, March 4 (Reuters) - Italy's Agnelli family has a 10.1% stake in New York-listed information services provider Clarivate 16A.F through their investment arm Exor EXOR.AS, the two companies said ...

AMSTERDAM (Reuters) - Exor NV, the investment arm of Italy's Agnelli family, has increased its stake in health technology company Philips to 18.7%, a filing at the U.S. Security and Exchange ...